Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3710691018 | Product containing loteprednol in ocular dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3710692013 | Loteprednol-containing product in ocular dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Loteprednol-containing product in ocular dose form | Is a | Loteprednol-containing product | true | Inferred relationship | Some | ||
| Loteprednol-containing product in ocular dose form | Has active ingredient | Loteprednol | true | Inferred relationship | Some | 1 | |
| Loteprednol-containing product in ocular dose form | Has manufactured dose form | Ocular dose form | true | Inferred relationship | Some | ||
| Loteprednol-containing product in ocular dose form | Is a | Product manufactured as ocular dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Loteprednol only product in ocular dose form | Is a | True | Loteprednol-containing product in ocular dose form | Inferred relationship | Some | |
| Loteprednol- and tobramycin-containing product in ocular dose form | Is a | True | Loteprednol-containing product in ocular dose form | Inferred relationship | Some | |
| Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Is a | False | Loteprednol-containing product in ocular dose form | Inferred relationship | Some |
Reference Sets
Australian dialect reference set
Unit of use quantity reference set
FHIR